Add BrightSurf on Google Email

First-of-its-kind cell therapy clinical trial led by Children’s National shows promising long-term survival in children with aggressive brain tumors

A Phase I trial evaluated a novel multi-targeted T-cell therapy for children with deadly brain tumors, offering early evidence that the patient's own immune cells can reach and fight tumors while producing fewer severe side effects. The study suggests a safer and more effective approach for pediatric brain cancers.

SourceChildren's National Hospital·JournalNature Medicine·DateJun 30, 2026

Shorter strides can be an early warning sign of dementia in senior dogs, just as in people

A new study has found that changes in a senior dog's gait can be an early warning sign of dementia. The research tracked the stride length of 88 geriatric dogs over time, revealing a significant decrease in front leg stride length with worsening cognitive decline. This change was found to be more pronounced than age-related decline alone.

SourceFrontiers·JournalFrontiers in Veterinary Science·TypeExperimental study·DateJun 25, 2026

Can brain damage in neuromyelitis optica spectrum disorder keep progressing silently?

A recent international MRI study found evidence of ongoing neurodegeneration in NMOSD patients, even when they are clinically stable and not experiencing flare-ups. The research suggests that subtle cognitive decline may occur even in the absence of relapses, with brain atrophy rates being faster in NMOSD patients compared to healthy v...

SourceChiba University·JournalJournal of Neurology Neurosurgery & Psychiatry·DateJun 18, 2026

Brain-computer interface enables independent, accurate communication for man living with ALS

A brain-computer interface (BCI) system has been developed at the University of California - Davis Health, allowing a person with severe paralysis caused by amyotrophic lateral sclerosis (ALS) to communicate, work, and interact with the digital world without assistance. The BCI system has been tested in a 47-year-old man with ALS, who ...

SourceUniversity of California - Davis Health·JournalNature Medicine·DateJun 15, 2026

Texas Children’s Hospital and Baylor College of Medicine researcher awarded up to $17.25 million to join an international autism research collaborative

Baylor College of Medicine researcher Dr. Jimmy Holder and his team will join the ARIA IMPACT Network to accelerate clinical trial readiness and implementation for promising therapies on autism. The collaboration aims to better understand how autism develops and changes over time in children with profound autism.

Video game stroke rehab restores arm movement in chronic stroke survivors

A new study from Northwestern University developed a customized video game to help chronic stroke survivors regain lost arm function. After six weeks of therapy, participants showed significant improvement in arm function and daily activities, with scores improving up to 7.8 times that of the control group.

SourceNorthwestern University·JournalNeurorehabilitation and Neural Repair·TypeRandomized controlled/clinical trial·DateJun 9, 2026

Neuropixels Opto sheds new light on deepest regions of the brain

Researchers have developed a new device called Neuropixels Opto that can record and manipulate neuron activity in the brain. The device, published in Nature Methods, integrates electrophysiology and optogenetics to provide unprecedented insight into neural circuits and neurological conditions such as Alzheimer's disease and schizophrenia.

SourceUniversity College London·JournalNature Methods·TypeExperimental study·DateJun 1, 2026

Virtual-reality path integration for predicting risk of neurodegenerative diseases

Researchers found that impaired virtual reality path integration was closely tied to brain structure and biomarkers associated with neurodegeneration. This suggests that VR-based navigation errors may reveal hidden changes in the brain long before symptoms arise, making it a promising behavioral marker for preclinical Alzheimer's disease.

SourceFujita Health University·JournalAlzheimer s Research & Therapy·TypeObservational study·DateMay 27, 2026

Chinese Neurosurgical Journal article finds that flow diversion devices are exceptionally safe

A long-term study of patients treated with flow diversion devices (FDDs) for intracranial aneurysms revealed excellent safety profiles, with no significant differences in outcomes between various FDD platforms. The study found that multiple FDDs were associated with a higher risk of insufficient closure and delayed complications.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeData/statistical analysis·DateMay 18, 2026

Chinese Medical Journal study examines rising neurological disease burden in China

A recent Chinese Medical Journal study analyzed data from 1990 to 2021, revealing a significant increase in neurological disorders such as dementia, Parkinson's disease, and ischemic stroke. The study identified a turning point coinciding with the COVID-19 pandemic, highlighting the need for coordinated national strategies to address t...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeMeta-analysis·DateMay 14, 2026

Chinese Neurosurgical Journal reports KRAS gene as key driver for brain arteriovenous malformation

A study published in Chinese Neurosurgical Journal reports KRAS gene overexpression associated with brain arteriovenous malformation (bAVM) pathogenesis. The research found altered gene expression profiles linked to cell adhesion, signaling, and mitochondrial function, suggesting KRAS-driven molecular alterations play a role in bAVM de...

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeExperimental study·DateMay 13, 2026

New experimental drug may restore movement after stroke

Researchers discovered that strokes cause a chain reaction within the brain, leading to neuronal cell death. They found that blocking collagen production can prevent this damage and even restore motor function in paralyzed monkeys. The new drug KDS12025 reduces hydrogen peroxide levels and prevents the entire process from being triggered.

SourceInstitute for Basic Science·JournalCell Metabolism·TypeExperimental study·DateApr 27, 2026

Low-dose triple-pill cut risk of recurrent stroke by about 40%, global trial shows

A global trial involving 1,670 patients with intracerebral haemorrhage found that treatment with a single pill combination of three low-dose blood pressure medicines reduced the risk of another stroke by 39%. The study showed significant benefits in reducing major cardiovascular events and improving blood pressure control.

SourceGeorge Institute for Global Health·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Patients with higher markers of marginalization more likely to rely on emergency departments for concussion care, study finds

A new study found that patients experiencing socioeconomic marginalization are more likely to seek initial concussion care in hospital emergency departments, leading to lower follow-up rates. Patients without family physicians were up to 70% less likely to follow up.

SourceInstitute for Clinical Evaluative Sciences·JournalJAMA Network Open·TypeObservational study·DateApr 22, 2026